Caen J - Search Results

1

Molecular basis of Glanzmann's Thrombasthenia and current strategies in treatment.

Bellucci S, Caen J. Bellucci S, et al. Among authors: caen j. Blood Rev. 2002 Sep;16(3):193-202. doi: 10.1016/s0268-960x(02)00030-9. Blood Rev. 2002. PMID: 12163005 Review.

2

Dissociation between fibrinogen and fibrin interaction with platelets in patients with different subtypes of Glanzmann's thrombasthenia: studies in an ex vivo perfusion chamber model.

Hainaud P, Brouland JP, André P, Simoneau G, Bal Dit Sollier C, Drouet L, Caen J, Bellucci S. Hainaud P, et al. Among authors: caen j. Br J Haematol. 2002 Dec;119(4):998-1004. doi: 10.1046/j.1365-2141.2002.03966.x. Br J Haematol. 2002. PMID: 12472580 Free article.

3

[Constitutional thrombopathies: from the clinical description of rare diseases (Glanzmann thrombasthenia and Bernard-Soulier syndrome) to the development of new antithrombotic agents].

Caen J, Bellucci S. Caen J, et al. Bull Acad Natl Med. 1998;182(7):1493-502; discussion 1502-3. Bull Acad Natl Med. 1998. PMID: 9916343 French.

4

Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin.

Gruel Y, Pacouret G, Bellucci S, Caen J. Gruel Y, et al. Among authors: caen j. Blood. 1997 Jul 15;90(2):888-90. Blood. 1997. PMID: 9226191 Free article. No abstract available.

5

Congenital platelet disorders.

Bellucci S, Caen JP. Bellucci S, et al. Among authors: caen jp. Blood Rev. 1988 Mar;2(1):16-26. doi: 10.1016/0268-960x(88)90004-5. Blood Rev. 1988. PMID: 3289650 Review.

6

Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with Anagrelide.

Bellucci S, Legrand C, Boval B, Drouet L, Caen J. Bellucci S, et al. Among authors: caen j. Br J Haematol. 1999 Mar;104(4):886-92. doi: 10.1046/j.1365-2141.1999.01234.x. Br J Haematol. 1999. PMID: 10192455 Free article.

7

Platelet aggregation is not necessary for occurrence of Raynaud's phenomenon: a clinical history and laboratory results.

Bellucci S, Kedra A, Bray P, Caen JP. Bellucci S, et al. Among authors: caen jp. Angiology. 1990 Nov;41(11):970-2. doi: 10.1177/000331979004101112. Angiology. 1990. PMID: 2244702

8

Impaired prothrombin consumption in Bernard-Soulier syndrome is corrected in vitro by human factor VIII.

Bellucci S, Girma JP, Lozano M, Meyer D, Caen JP. Bellucci S, et al. Among authors: caen jp. Thromb Haemost. 1997 Feb;77(2):383-6. Thromb Haemost. 1997. PMID: 9157600

9

[Blood platelets].

Caen J, Bellucci S. Caen J, et al. Bull Acad Natl Med. 2013 Feb;197(2):343-7. Bull Acad Natl Med. 2013. PMID: 24919364 French.

10

[New treatments for Raynaud's syndrome].

Bellucci S, Kedra W, Ajzenberg N, Tobelem G, Caen J. Bellucci S, et al. Among authors: caen j. Nouv Rev Fr Hematol (1978). 1988;30(1-2):103-7. Nouv Rev Fr Hematol (1978). 1988. PMID: 3290833 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

622 results

Search Page

Filters